SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-114687
Filing Date
2024-10-15
Accepted
2024-10-15 16:15:08
Documents
1
Period of Report
2024-10-10

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3819
  Complete submission text file 0000950170-24-114687.txt   5252
Mailing Address C/O IDENIX PHARMACEUTICALS, INC. 60 HAMPSHIRE STREET CAMBRIDGE MA 02109
Business Address
Renaud Ronald C JR (Reporting) CIK: 0001354434 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42366 | Film No.: 241371995

Mailing Address 890 WINTER STREET, SUITE 200 WALTHAM MA 02451
Business Address 890 WINTER STREET, SUITE 200 WALTHAM MA 02451 781-208-2466
Upstream Bio, Inc. (Issuer) CIK: 0002022626 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)